Related Experiment Video
Updated: Apr 26, 2026

04:48
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
8.7K
[NMDA-type glutamate receptor and schizophrenia]
Summary
Reduced NMDA receptor function may cause schizophrenia symptoms. Targeting NMDA receptor pathways offers potential new treatments for schizophrenia, addressing both responsive and resistant conditions.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Context:
- Schizophrenia pathophysiology is complex, with glutamate system dysfunction a key area of investigation.
- NMDA receptor antagonists, like phencyclidine, induce schizophrenia-like symptoms in healthy individuals and patients.
- Autoimmune encephalitis targeting NMDA receptors can manifest with psychosis.
Purpose:
- To explore the role of N-methyl-D-aspartate (NMDA) receptor hypofunction in schizophrenia.
- To investigate the therapeutic potential of modulating NMDA receptor activity for schizophrenia treatment.
Summary:
- Evidence suggests reduced NMDA receptor neurotransmission contributes to schizophrenia's positive, negative, and cognitive symptoms.
- NMDA receptor antagonist effects correlate with their blocking efficacy and can induce psychosis in vulnerable individuals.
- Potential therapeutic strategies involve enhancing glycine site function or reducing glutamate release to target schizophrenia.
Impact:
- This research supports novel pharmacotherapies for schizophrenia, potentially improving outcomes for antipsychotic-responsive and resistant cases.
- Understanding NMDA receptor hypofunction offers new avenues for treating schizophrenia and related psychotic disorders.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.5K
Biological Causes of Schizophrenia
1.2K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K
Ligand-gated Ion Channels
11.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
11.4K
Excitatory and Inhibitory Effects of Neurotransmitters
11.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
11.9K

